Physician profile
Todd E Rasmussen
NPI 1093725707
$560,672.01
in general payments reported to CMS, 2019-2025
7 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $793 · 2021: $150K · 2022: $183K · 2023: $180K · 2024: $46K · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $225K · Food and Beverage: $933 · Travel and Lodging: $526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $225,000.00 |
| Food and Beverage | $933.48 |
| Travel and Lodging | $525.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prytime Medical Devices, INC. | $559,018.22 | 2019-2024 | Er-Reboa Plus |
| Silk Road Medical, INC. | $734.06 | 2019 | |
| W. L. Gore & Associates, INC. | $662.48 | 2022-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Bolton Medical INC | $185.81 | 2021-2024 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Abbott Laboratories | $46.19 | 2024 | Esprit |
| Mindray Ds USA, INC. | $25.25 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Rasmussen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.